Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr609 Inhibitors

Olfr609, a member of the olfactory receptor family, stands as a pivotal player in the intricate olfactory signaling cascade, contributing to the sensory perception of diverse odorant molecules. As a G protein-coupled receptor (GPCR), Olfr609 engages in the recognition and transduction of specific olfactory stimuli, initiating downstream events that culminate in the perception of odors. Functionally, Olfr609 is entwined in a web of cellular pathways, including the Ergosterol biosynthesis, Notch signaling, AMP-activated protein kinase (AMPK), HSP90, PPARγ, sphingosine-1-phosphate receptors, ERK5, PI3K/Akt, endoplasmic reticulum calcium stores, and the MEK/ERK pathway. The inhibition of Olfr609 unfolds through a repertoire of chemicals that act as both direct and indirect inhibitors. Ketoconazole, for instance, functions as an indirect inhibitor by targeting the Ergosterol biosynthesis pathway, causing downstream alterations that negatively regulate Olfr609 expression. In parallel, DBZ (Dibenzazepine) inhibits Olfr609 through interference with the Notch signaling pathway, disrupting downstream cascades and negatively affecting Olfr609 function within cellular contexts. These inhibitors collectively underscore the intricate regulatory network governing Olfr609 activity, offering insights into potential strategies for modulating olfactory perception.

Indirect inhibitors, such as FTY720 (Fingolimod) and Wortmannin, modulate sphingosine-1-phosphate receptors and the PI3K/Akt pathway, respectively, leading to downstream alterations that negatively regulate Olfr609 expression and function. Specific interference with the MEK/ERK pathway by PD98059 and disruption of endoplasmic reticulum calcium stores by Thapsigargin illustrate the interconnected nature of olfactory signal transduction pathways. The diverse mechanisms of inhibition highlight the multifaceted nature of olfactory receptor regulation, opening avenues for further exploration into the molecular intricacies of olfactory perception. In summary, Olfr609 serves as a molecular mediator in olfactory signal transduction, with its inhibition governed by a variety of chemicals influencing key cellular pathways associated with its function. The interplay between these inhibitors and the intricate pathways linked to Olfr609 underscores the complexity of olfactory receptor regulation, providing valuable insights into potential strategies for modulating olfactory perception.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$63.00
$265.00
21
(1)

Ketoconazole serves as an indirect inhibitor by targeting the Ergosterol biosynthesis pathway. Inhibition of Ergosterol synthesis leads to downstream alterations that negatively regulate Olfr609 expression.

Dibenzazepine (Deshydroxy LY 411575)

209984-56-5sc-207554
sc-207554A
2 mg
5 mg
$235.00
$260.00
4
(1)

DBZ inhibits Olfr609 through specific interference with the Notch signaling pathway. Its action on Notch disrupts downstream signaling cascades, negatively affecting Olfr609 function within cellular contexts.

BML-275

866405-64-3sc-200689
sc-200689A
5 mg
25 mg
$96.00
$355.00
69
(1)

Compound C acts as an indirect inhibitor by targeting AMP-activated protein kinase (AMPK). Inhibition of AMPK disrupts downstream signaling cascades, negatively influencing Olfr609 function.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

Tanespimycin serves as a direct inhibitor by targeting HSP90. Inhibition of HSP90 disrupts downstream chaperone activities, negatively impacting Olfr609 function within the cellular context.

GW 9662

22978-25-2sc-202641
5 mg
$70.00
30
(2)

GW9662 acts as an indirect inhibitor by interfering with peroxisome proliferator-activated receptor-gamma (PPARγ). Its action on PPARγ disrupts downstream events that negatively regulate Olfr609 expression.

FTY720

162359-56-0sc-202161
sc-202161A
sc-202161B
1 mg
5 mg
25 mg
$33.00
$77.00
$120.00
14
(1)

FTY720 inhibits Olfr609 through modulation of sphingosine-1-phosphate receptors. Its impact on sphingosine signaling disrupts downstream cascades, negatively affecting Olfr609 function within cellular contexts.

XMD 8-92 (free base)

1234480-50-2sc-364068
sc-364068A
sc-364068B
sc-364068C
5 mg
10 mg
100 mg
1 g
$235.00
$340.00
$1700.00
$10330.00
10
(0)

XMD8-92 inhibits Olfr609 through specific interference with the ERK5 signaling pathway. Its action on ERK5 disrupts downstream signaling cascades, negatively affecting Olfr609 function within cellular contexts.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 serves as an indirect inhibitor by targeting PI3K. Its interference with PI3K disrupts downstream Akt signaling, negatively impacting Olfr609 function within the cellular environment.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin inhibits Olfr609 through disruption of the endoplasmic reticulum calcium stores. The altered calcium homeostasis negatively affects Olfr609 signaling and overall cellular impact.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 inhibits Olfr609 through specific interference with the MEK/ERK pathway. Its action on MEK disrupts downstream ERK activation, negatively affecting Olfr609 function within cellular contexts.